Repertoire Immune Medicines has collaborated with Eli Lilly for the development of tolerising therapies to treat several ...

The US Food and Drug Administration (FDA) will start accepting applications for the new PreCheck scheme that will streamline ...

AstraZeneca has returned to CSPC with a licensing deal for the Chinese company’s monthly injectables for obesity.

Sanofi's sales grew 9.9% YoY – driven by a diverse range of portfolio classics and new launches across immunology, oncology and rare disease.

This year, sales of Eliquis (apixaban) are projected to decline by 15.2% due to the loss of its European market exclusivity ...

IQVIA has announced a strategic, long-term partnership with Boehringer Ingelheim focused on strengthening data capabilities across therapeutic areas.

The FDA has granted breakthrough therapy designation to Biogen’s litifilimab for CLE, a chronic autoimmune skin condition.

The two companies reportedly could not agree on a price, leaving pharma’s first potential megadeal of 2026 on ice.

Roche’s adjusted operating profit rose by a lower-than-expected 5% in 2025, due to the weakened US dollar, despite the ...

Lilly and German biotech Seamless Therapeutics will develop recombinase-based treatments for hearing loss. In a move that ...

Other countries in Europe to lose eliminated status include Armenia, Austria, Azerbaijan, Spain, and Uzbekistan. Sustained ...